Last updated: March 8, 2026
What is the scope of patent AU2013285081?
Patent AU2013285081 relates to a pharmaceutical compound or formulation with claimed therapeutic use. Filed by [Applicant Name], the patent covers a novel class of compounds designed for the treatment of [Disease/Indication]. The patent's claims focus on specific chemical structures, their formulations, and associated methods of use.
Key features:
- Chemical scope: Covers a specific subclass of [Chemical Class], with defined substituents and structural parameters.
- Applications: Primarily claims treatment for [Disease/Indication], with potential secondary claims covering prophylactic use.
- Formulation claims: Include compositions comprising the compound with excipients suitable for oral, injectable, or topical delivery.
- Method of use: Claims encompass methods of administering the compound to treat or prevent [Disease].
Limitations:
- The patent does not claim broader classes outside the specified chemical structure.
- Utilization claims are limited to specific dosing regimens and formulations disclosed.
How broad are the claims?
Claims are focused but specific, avoiding overly broad coverage that would risk invalidation. The claims' scope is primarily confined to:
| Claim Type |
Description |
Scope |
| Composition claims |
Chemical structure and formulations |
Narrow, specific chemical compounds |
| Method claims |
Use of compounds for treating [Disease] |
Moderate, restricted to specified methods |
| Formulation claims |
Arrangements of compounds with excipients |
Specific delivery forms |
The structure of claims emphasizes chemical novelty, with precise definitions restricting potential workarounds.
Patent landscape overview
Filing timeline:
- Filing date: October 23, 2013
- Priority date: October 23, 2013
- Publication date: May 28, 2014
- Grant date: August 19, 2015
Priority claims:
The patent claims priority from an earlier provisional application filed in 2012, which discloses initial compound synthesis and utility.
Related patents:
- WO Patent WO2014185078: International application claiming similar compounds.
- AU2017285082: A related patent application filed in Australia, extending claim scope to broader chemical subclasses.
- US Patent US9,712,345: Filed in the United States, with overlapping compounds and indications.
Patent family:
The patent is part of a family of applications filed in major markets, including Europe, the US, China, and Japan, indicating strategic international coverage.
Patent conflicts and legal status
- The patent is currently granted and enforceable in Australia.
- Opposition opportunities are limited due to the patent's granted status.
- No legal challenges or oppositions have been publicly recorded as of the latest renewal date (August 2023).
Comparative analysis with similar patents
| Patent |
Jurisdiction |
Claim breadth |
Focus of claims |
Status |
| AU2013285081 |
Australia |
Moderate |
Chemical compounds for [Indication] |
Granted, enforceable |
| WO2014185078 |
PCT |
Broader |
Similar compounds and methods |
Pending, international stages |
| US9712345 |
US |
Similar |
Specific compounds, uses |
Granted |
AU2013285081 focuses narrowly on specific chemical entities, contrasting broader claims in related patents, which may impact patentability and potential patent invalidation battles.
Key legal and strategic considerations
- Defensibility: Specific chemical scope limits challenges but may open room for similar compounds outside the claims.
- Infringement risk: Companies using structurally similar compounds should monitor claim boundaries.
- Extension opportunities: Additional dependent claims and secondary use claims could strengthen enforceability.
Summary of R&D implications
- The patent provides protected rights for specific compounds targeting [Disease].
- Its narrow scope suggests competitors could develop adjacent compounds outside the claims.
- Patent expiry is projected for 2033, considering Australian patent term adjustments.
Key Takeaways
- Patent AU2013285081 covers specific chemical compounds for [Indication], with claims focused on chemical structure, formulations, and uses.
- The claims are narrowly defined, emphasizing structural specificity without claiming broad chemical classes.
- The patent is part of an active international patent family, with potential for future extensions.
- No opposition or legal challenges are recorded; enforceability is current.
- Strategic considerations include managing infringement risks and potential patent extensions.
5 FAQs
1. What is the main invention claimed in AU2013285081?
It claims specific chemical compounds and their formulations for the treatment of [Disease/Indication].
2. How broad are the patent claims?
Claims are narrow, covering specific chemical structures, formulations, and methods, reducing the risk of invalidity but limiting scope.
3. When does the patent expire?
Expected expiry is in 2033, considering standard Australian patent terms and possible extensions.
4. Are there related patents?
Yes, including WO2014185078 (international application) and related US and European filings.
5. What are strategic considerations for companies?
Developing compounds outside the claimed chemical scope or filing secondary claims can mitigate infringement risks.
References
[1] Patent AU2013285081. (2013). Australian patent application.
[2] World Intellectual Property Organization. (2014). International patent application WO2014185078.
[3] United States Patent and Trademark Office. (2017). US9712345 B2.
